PROSPECTS AND OPPORTUNITIES
Analgesics set to remain in demand with further innovation epxected
Value sales of analgesics are expected to rise over the forecast period overall, given their essential role in managing pain levels in chronic conditions. Coupled with the scheduling changes for paracetamol, the Chemist Warehouse-Sigma Healthcare merger is expected to reshape the analgesics landscape, influencing product assortment, pricing strategies, in-store positioning, and promotional activity.
Australian Government prioritises accessibility of healthcare solutions
Given the prevalence of chronic pain in the lives of Australians, it is no surprise that there are a range of digital and technological innovations to help local consumers reduce and manage the impact of chronic pain. For instance, Healthdirect, the national health advice service in Australia has a number of health and wellbeing apps and online programmes freely available via its website.
CSR and sustainability developments come to the fore
While Australian consumers are increasingly interested in sustainability, it is generally considered that this is the responsibility of the manufacturers, rather than for the consumer to pay a premium, particularly in a price-sensitive environment. From a global perspective, the leading players Haleon Plc and Reckitt Benckiser Group Plc (RB) are investing in cutting their total carbon footprint.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Australia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Australia?
- Which are the leading brands in Analgesics in Australia?
- How are products distributed in Analgesics in Australia?
- How has the regulatory and operating environment for Analgesics changed in Australia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Australia - Category analysis
KEY DATA FINDINGS
Focus on chronic pain shaping demand for OTC analgesics
The competitive landscape within analgesics is shaped by strategic business restructuring, consumer demand and community involvement in 2025
Scheduling changes and mergers impact pharmacies
Analgesics set to remain in demand with further innovation epxected
Australian Government prioritises accessibility of healthcare solutions
CSR and sustainability developments come to the fore
Consumer Health in Australia - Industry Overview
Consumer health in 2025: The big picture
2025 Key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!